Related by context. All words. (Click for frequent words.) 69 rTMS 69 magnetic stimulation 67 repetitive transcranial magnetic stimulation 67 electro acupuncture 66 paricalcitol 66 transcranial magnetic stimulation TMS 65 transcranial magnetic stimulation 65 pyridostigmine 63 electrostimulation 63 premotor 62 current stimulation tDCS 62 anterior temporal lobe 62 cortical stimulation 62 potentiation 61 TNF inhibitor 61 planum temporale 61 neurotrophic 61 denervation 61 rhTSH 61 cold pressor test 61 anticholinergics 61 lesional 61 cardioprotection 61 topical anesthesia 61 triamcinolone 61 cortical regions 60 rt PA 60 cortical excitability 60 inotropic agents 60 APTIVUS r 60 mPFC 60 GPi 60 atypical neuroleptics 60 pressor response 60 electrophysiologic 60 L dopa 60 gamma oscillations 60 dobutamine 60 nerve conduction velocity 60 neuroimaging studies 59 DLPFC 59 simulated acupuncture 59 cediranib 59 allodynia 59 transcranial direct 59 trastuzumab Herceptin ® 59 antihypertensive therapy 59 NMES 59 intraventricular 59 N acetylcysteine 59 hyperalgesia 59 cortical activation 59 poststroke 59 noninvasive technique 59 electroencephalographic 59 electrical stimulation 59 NLX P# 59 flavopiridol 59 perfusion MRI 59 microelectrode array 58 sham acupuncture 58 hemiparesis 58 remyelination 58 vasodilation 58 phasic 58 TACE 58 SGS# 58 locomotor training 58 Spinal manipulation 58 fulvestrant 58 fMRI scans 58 orbital frontal cortex 58 baclofen 58 neuronal plasticity 58 lateral orbitofrontal cortex 58 beta adrenergic receptors 58 intravitreal injections 58 laser photocoagulation 58 electroacupuncture 58 siRNA knockdown 58 intravenous cyclophosphamide 58 aromatase inhibitor therapy 58 analgesic medications 58 hippocampal neurons 58 sensorimotor 58 guanfacine 58 AGILECT R 58 imipramine 58 metabolic parameters 58 temporoparietal 57 hypoperfusion 57 neural plasticity 57 INVEGA ™ 57 bezafibrate 57 locomotor activity 57 nondominant 57 primidone 57 isoproterenol 57 myogenic 57 photocoagulation 57 clomipramine 57 norepinephrine reuptake inhibition 57 ACh 57 antiandrogens 57 mdx mice 57 MGd 57 minocycline 57 anticholinergic drugs 57 verum acupuncture 57 secretin 57 daunorubicin 57 photoactivation 57 coronary endothelial 57 CYP#A# inhibitors 57 pharmacodynamic parameters 57 mGluR5 antagonist 57 hyperoxia 57 cranial irradiation 57 fusiform 57 therapy 57 intra arterial 57 inhibitory neurotransmitters 57 CYP#D# inhibitors 57 mu opioid 57 cerebral ischemia 57 surgical decompression 57 baroreflex 57 antidepressant therapy 57 inferior parietal lobule 57 pentoxifylline 57 somatosensory 57 rFVIIa 57 immunosuppressive agents 57 miglustat 57 CPAP adherence 57 corticosteroid therapy 57 TGF ß 57 ritonavir boosted 57 dexmedetomidine 57 generalized epilepsy 57 pituitary hormone 57 neuroleptics 57 dose proportionality 57 brainwave patterns 57 nelfinavir 57 aspirin clopidogrel 57 rHuEPO 57 intramyocardial 57 teriparatide 57 dorsolateral prefrontal cortex 57 gadobutrol 57 DSAEK 57 genotypic resistance 57 fibrinolysis 57 hippocampal neurogenesis 57 anterior cingulate 57 occipital cortex 57 autoregulation 57 receptor subtypes 57 ginkgo extract 57 pramipexole 57 concurrent chemoradiation 57 IFN beta 57 GAMMAGARD 57 parietal cortices 57 motoneurons 57 TNFa 56 anxiolytic 56 extrapyramidal symptoms 56 riociguat 56 reflux symptoms 56 β blockers 56 irbesartan 56 allogeneic transplant 56 decompressive surgery 56 antiplatelet therapies 56 neural prosthetics 56 infarct size 56 biventricular pacing 56 peginterferon 56 reinnervation 56 nerve regrowth 56 LLLT 56 zolmitriptan 56 dopamine neuron 56 cognitive domains 56 hepatic fibrosis 56 PC# cells 56 hypometabolism 56 exploratory endpoints 56 amblyopic eye 56 myeloablative 56 cardioplegic arrest 56 OPCAB 56 L DOPA 56 rCBF 56 LVRS 56 EEGs 56 intra arterial chemotherapy 56 glutamate receptors 56 neuronal signaling 56 IBMT 56 androgen blockade 56 sensory cortex 56 auditory cortices 56 IGFBP 3 56 euthymic patients 56 transaminase elevations 56 dosage regimens 56 kainate 56 tolterodine 56 hematologic parameters 56 antiepileptic drugs AEDs 56 mTOR inhibitors 56 neurotransmitter GABA 56 TNF alpha inhibitor 56 standard chemotherapy regimens 56 visuomotor 56 CaM kinase II 56 baroreceptor 56 neural cells 56 laterality 56 anterior temporal 56 transcranial 56 glaucomatous 56 callus formation 56 platelet aggregation 56 transthoracic 56 resynchronization therapy 56 full thickness plication 56 tenecteplase 56 saline injections 56 troponins 56 immunoreactivity 56 intima media thickness 56 TNF antagonist 56 lateral habenula 56 weekly subcutaneous injections 56 thrombolytic agents 56 anterior insula 56 oral corticosteroid 56 craniectomy 56 medial frontal cortex 56 Doxil ® 56 sulfasalazine 56 Corticosteroid injections 56 Parkinsonian 56 tissue plasminogen activator tPA 56 pulmonary artery banding 56 TriRima 56 prefrontal brain 56 inotropic 56 experimentally induced 56 acupoint 56 aminotransferases 56 adrenal function 56 glutamate signaling 56 nicotinic acid 56 lateral prefrontal cortex 56 Dr. Borlongan 56 transgene expression 56 myocytes 56 Photodynamic therapy 56 psychophysiological 56 somatic symptoms 56 synaptic transmission 56 somatosensory evoked potentials 56 acupoints 56 urothelial cancer 56 chemotherapeutic regimens 56 oxcarbazepine 56 steroid dexamethasone 56 cilostazol 56 allergic airway inflammation 56 nociception 56 antioxidant supplementation 55 CANCIDAS 55 adefovir 55 spinal manipulation 55 proliferative diabetic retinopathy 55 docetaxel chemotherapy 55 neurite outgrowth 55 Leydig cell 55 ejection fractions 55 typical antipsychotics 55 MBCT 55 antibody mediated 55 JAK STAT signaling 55 neuro pathways 55 5FU 55 proton pump 55 antiepileptic medications 55 radiographic progression 55 mg Pycnogenol 55 femoral fractures 55 Subgroup analysis 55 myocyte 55 DAPT 55 decitabine 55 generalized seizures 55 HUCB cells 55 hyperactivation 55 intravenous dosing 55 electrophysiological 55 ventricular enlargement 55 acetylcysteine 55 verteporfin 55 tocilizumab 55 lenalidomide dexamethasone 55 intravenous bisphosphonates 55 recombinant tissue plasminogen 55 preoperative chemotherapy 55 prefrontal regions 55 neurophysiologic 55 pharmacodynamic endpoints 55 losartan 55 colorectal cancer liver metastases 55 griseofulvin 55 idarubicin 55 EEG biofeedback 55 RRMS patients 55 depolarizing 55 methotrexate monotherapy 55 APTIVUS R 55 solifenacin 55 TGF beta signaling 55 nocturnal hemodialysis 55 mycophenolate mofetil 55 hip resurfacing arthroplasty 55 allopregnanolone 55 RF ablation 55 methylprednisolone 55 adult neurogenesis 55 Sjögren syndrome 55 adrenalectomy 55 glutamate neurotransmission 55 neuropilin 55 magnetic pulses 55 amyloid deposition 55 WBPA 55 ALA PDT 55 acupoint stimulation 55 uric acid lowering 55 intensive statin therapy 55 hyaluronic acid fillers 55 clinically meaningful improvements 55 Radiofrequency ablation 55 thiazide 55 vagal nerve 55 diastolic function 55 F FDG PET 55 etanercept 55 synaptic function 55 brain lesions 55 rostral anterior cingulate cortex 55 gyrus 55 thrombus aspiration 55 opioid analgesia 55 HPA axis 55 antiangiogenic 55 vorinostat 55 hypovolemic 55 oculomotor 55 immunomodulatory therapy 55 vagal 55 neuromodulator 55 esomeprazole 55 status epilepticus 55 revascularization procedures 55 PREZISTA rtv 55 NAbs 55 aldosterone antagonist 55 dexrazoxane 55 cortical dysplasia 55 DMARD therapy 55 liver histology 55 electrodes implanted 55 timepoints 55 parahippocampal gyrus 55 perfusion abnormalities 55 PECAM 1 55 myocardial reperfusion 55 arteriography 55 myocardial tissue 55 endoxifen 55 acetyl L carnitine 55 osteoblast 55 anti androgen 55 occipital regions 55 valproic acid 55 T2 lesions 55 demethylation 55 akinetic mutism 55 costimulatory 55 neurogenic 55 paliperidone 55 DMARDs 55 neovascularization 55 FGF2 55 Electromyography 55 stimulation TENS 55 Electrical stimulation 55 subthalamic 55 NMDA receptors 55 chemoradiation therapy 55 collagen crosslinking 55 recurrent glioblastoma multiforme 55 carvedilol 55 DMARD 55 glomerular filtration 55 pharmacokinetic parameters 55 IL 1ß 55 tacrolimus ointment 55 atherosclerotic lesions 55 humoral antibody 55 HAART regimen 55 etoposide 55 rolipram 55 argatroban 55 mitoxantrone 55 binocular rivalry 55 indomethacin 55 CONCERTA ® 55 acamprosate 55 EDSS scores 55 VADT 55 rosuvastatin #mg 55 allogeneic SCT 55 urate lowering therapy 55 nerve stimulation 55 antiemetics 55 spinal cord stimulation 55 VA# [002] 55 LHRH agonists 55 MMP inhibitors 55 EEG recordings 55 somatostatin analogs 55 hypertonic saline 55 TEAEs 55 calcitriol 55 paroxysmal AF 55 somatosensory cortex 55 trabeculectomy 55 olmesartan 55 enalapril 55 intermittent hypoxia 54 colorectal liver metastases 54 calcineurin 54 saline placebo 54 anatomic structures 54 SIRT1 activation 54 plus methotrexate 54 IDH1 mutation 54 trials RCTs 54 erythropoiesis 54 INVEGA ® 54 osteoclast 54 virological response 54 citalopram 54 nonoperative treatment 54 pDCs 54 amisulpride 54 prodromal symptoms 54 serotonin synthesis 54 QTc prolongation 54 neural tissues 54 GnRH agonists 54 anticancer therapy 54 occipital nerve 54 neuropathologic 54 somatostatin analog 54 psychodynamic psychotherapy 54 cranial radiation 54 trans cranial 54 nonpharmacologic 54 CHOP chemotherapy 54 cortical neurons 54 antihypertensive agents 54 reperfusion therapy 54 pregabalin 54 Paliperidone 54 conventional angiography 54 saccade 54 Visual acuity 54 postural sway 54 postoperative chemotherapy 54 ziconotide 54 neurotransmitter receptor 54 FOLPI 54 mechanical dyssynchrony 54 pegaptanib 54 transcranial Doppler 54 selective cerebral perfusion 54 neurosensory 54 PNES 54 oncologic outcomes 54 overactive bladder symptoms 54 ipRGCs 54 hypotensive 54 VitalStim 54 alpha blocker 54 microdebrider 54 remifentanil 54 Non inferiority 54 taxane chemotherapy 54 corticospinal 54 serotonin neurons 54 #HT#A 54 creatine supplementation 54 choroidal neovascularization 54 hippocampal volume 54 serum cortisol 54 insulin detemir 54 Revascor TM 54 fluvastatin 54 mg kg dose 54 CT perfusion 54 intracranial hypertension 54 parasympathetic tone 54 AMPA receptor 54 chiropractic adjustment 54 AV node 54 NAcc 54 meta cognitive 54 GABA receptor 54 Notch signaling 54 desvenlafaxine succinate 54 wavefront guided LASIK 54 nerve degeneration 54 percutaneous tibial nerve 54 stem cell transplantations 54 FOLFIRINOX 54 iloprost 54 methotrexate therapy 54 BMP signaling 54 BoNTA 54 eplerenone 54 beta interferon 54 medial prefrontal 54 inosine 54 DRG neurons 54 agomelatine 54 urography 54 ERK1 2 54 osteogenesis 54 Inhaled nitric oxide 54 saccades 54 temporoparietal junction 54 6 OHDA 54 BDNF protein 54 extracorporeal shock wave 54 Transcranial Magnetic Stimulation 54 neurologic deficits 54 morphometric vertebral fractures 54 alteplase 54 NRG1 54 hypothalamic pituitary adrenal axis 54 Transcranial magnetic stimulation 54 milrinone 54 adriamycin 54 tranylcypromine 54 multivariate analyzes 54 axonal damage 54 pro angiogenic 54 ouabain 54 nasal obstruction 54 NMDA receptor 54 chemotherapeutic drug 54 LT NS# 54 Purkinje cell 54 posterior parietal cortex 54 myoblast therapy 54 androgen deprivation 54 axillary lymph node dissection 54 cAMP signaling 54 IKK2 54 clot dissolving drug 54 serotonergic 54 photon laser 54 vitamin D analogs 54 spectroscopy MRS 54 myocardial perfusion 54 pars plana vitrectomy 54 neurotrophic factors 54 paracentesis 54 clot busting therapy 54 PREZISTA r 54 Janicak 54 tissue oxygenation 54 hyperexcitability 54 rhGH 54 anticancer treatments 54 beta adrenergic 54 gemifloxacin 54 glargine 54 SCIg 54 pegylated liposomal doxorubicin 54 ropinirole 54 renal toxicity 54 chemoradiotherapy 54 idraparinux 54 gastrointestinal motility 54 bosentan 54 medically refractory 54 efalizumab 54 primary aldosteronism 54 hyperintense lesions 54 APTIVUS 54 dyskinesias 54 electromyography 54 nonmelanoma skin cancers 54 PDGF BB 54 hypofractionated radiation 54 nerve grafts 54 middle frontal gyrus 54 postural stability 54 metreleptin 54 BDNF gene 54 poststroke depression 54 schwannomas 54 TRPV1 receptors 54 prazosin 54 amygdalae 54 epidural steroid injection 54 interpersonal psychotherapy 54 physiologic responses 54 virologic response 54 paramagnetic 54 monoamines 54 reuptake inhibitors 54 DMARDS 54 transarterial chemoembolization 54 cerebral angiography 54 raltegravir 54 p# activation 54 nortriptyline 54 posttreatment 54 motor neuron degeneration 54 Neovascular AMD 54 D2 receptors 54 Platinol ® cisplatin 54 lipid lowering agents 54 chlorpromazine 54 PsA 54 extreme dreaders 54 nonresponders 54 myoclonus 54 attentional blink 54 antihypertensive drugs 54 tipranavir 54 chronotherapy 54 HIF 1a 54 flecainide 54 vagal nerve stimulation 53 insulin sensitization 53 antidiabetic drugs 53 radioiodine therapy 53 factor Xa 53 fibrinolytic therapy 53 Tacrolimus 53 RQ PCR 53 dimensional echocardiography 53 neuromotor 53 contractility 53 cidofovir 53 diplopia 53 probiotic supplementation 53 postoperative complication 53 Th2 immune 53 leptin deficient mice 53 indinavir 53 neural pathway 53 striatal 53 multicenter clinical trials 53 prefrontal cortical 53 enzymatic pathways 53 Inosine 53 thyroglobulin 53 Neuropeptide Y 53 neurologic symptoms 53 microelectrode 53 oral antidiabetes drugs 53 Gleevec resistant 53 neuroprotection 53 external beam radiotherapy 53 nonmetastatic prostate cancer 53 neuronal stem cells 53 donepezil 53 nitazoxanide 53 RAS blockers 53 anti CD3 antibody 53 bronchial thermoplasty 53 neurologic progression 53 sonographic guidance 53 subscapularis 53 benfotiamine 53 hypericin 53 Hypotension 53 MMSE scores 53 EGFr 53 zoledronate 53 synesthetes 53 platelet inhibition 53 cardiac autonomic 53 blood oxygenation 53 PDGF receptor 53 superficial bladder cancer 53 d4T 53 MT1 MMP 53 plain radiographs 53 infarcts 53 androgen suppression 53 hemodynamic parameters 53 antidepressant efficacy 53 hematopoietic cancers 53 intra articular 53 NMDA receptor antagonists 53 Surgical excision 53 neoadjuvant radiation 53 left ventricular diastolic 53 CIMZIA TM 53 neuromuscular electrical stimulation 53 pupillary light 53 subthalamic nucleus 53 acromegalic patients 53 chiropractic manipulation 53 PREZISTA ritonavir 53 skin conductance responses 53 vasomotor 53 TGF ß1 53 anticonvulsant medication 53 Ginkgo extract 53 EVIZON 53 SPECT imaging 53 NUCYNTA R 53 antiangiogenic therapy 53 subthalamic nucleus STN 53 dorsal prefrontal cortex 53 venlafaxine 53 verbal fluency 53 perfusion defects 53 hippocampal atrophy 53 choroidal vasculopathy 53 glucose lowering 53 intra ocular pressure 53 idiopathic Parkinson disease 53 tau aggregates 53 atrioventricular 53 FFNS 53 levodopa therapy 53 hippocampal function 53 nonlinear optical 53 ancrod 53 iniparib 53 cellularity 53 primary visual cortex 53 darunavir ritonavir 53 tolvaptan 53 analgesic effects 53 neural substrates 53 constipation predominant IBS 53 immunomodulatory therapies 53 placebo 53 Foxp3 53 cholinergic 53 gemcitabine Gemzar 53 dopaminergic 53 teriflunomide 53 intracranial stenosis 53 skeletal myoblasts 53 DACH platinum 53 muscarinic receptors 53 intractable hiccups 53 fibrate drugs 53 active comparator 53 Akt activation 53 histopathologic examination 53 tactile stimulation 53 mirror neuron 53 5 HT2A receptor 53 ventral prefrontal cortex 53 FluCAM 53 CsA 53 peg interferon 53 IgG1 antibodies 53 interferon alfa 2b 53 ischemia induced 53 sustained virologic response 53 IFN γ 53 oral rivaroxaban 53 intracoronary 53 temozolomide 53 Retisert 53 LVEF 53 interferon ribavirin 53 hyperinsulinemic euglycemic clamp 53 EGFR inhibitors 53 vessel dilation 53 neuronal differentiation 53 chemotherapy docetaxel 53 neuropsychological tests 53 weekly intravenous infusions 53 tryptophan depletion 53 HCV replication 53 visilizumab 53 melanopsin 53 nutlin 53 antiepileptics 53 adenosine diphosphate ADP 53 #mg dose [001] 53 radiotracer 53 hemiplegia 53 ADAMTS# 53 white matter hyperintensities 53 virologic breakthrough 53 calcium homeostasis 53 electrically stimulated 53 antitumor responses 53 methacholine challenge 53 Doppler echocardiography 53 pharmacologic 53 ablative therapy 53 mitomycin C 53 treating neuropathic pain 53 intraocular pressure IOP 53 BH4 53 electromyogram 53 superior temporal sulcus 53 neurite 53 SIRT1 protein 53 caspofungin 53 insular cortex 53 extensor 53 intestinal motility 53 hemodynamic responses 53 psychostimulants 53 cerebral perfusion 53 multitargeted 53 anti angiogenic agents 53 corifollitropin alfa 53 nNOS 53 STAT3 signaling 53 cisplatin chemotherapy 53 seminomas 53 ASC J9 53 SSRI citalopram 53 plasma pharmacokinetics 53 synaesthetes 53 JAK STAT 53 phenelzine 53 DFMO 53 hepatic lesions 53 noxious stimuli 53 neurosteroid 53 fibrin deposition 53 acoustic startle 53 LIPUS 53 calcaneal fractures 53 dopaminergic therapy 53 intraperitoneal chemotherapy 53 CCR5 receptors 53 Cortisone injections 53 rufinamide 53 azacitidine 53 evoked potentials 53 islet transplant 53 aortic insufficiency 53 ELOXATIN 53 anticoagulant warfarin 53 hyperprolactinemia 53 repolarization 53 EUFLEXXA R 53 habenula 53 Stroop task 53 mild electrical stimulation 53 ximelagatran 53 transesophageal echocardiography 53 premotor cortex 53 neuromuscular junction 53 elastase 53 hERG channel 53 captopril 53 apoptotic pathway 53 dystrophic mice 53 tamsulosin 53 beta lactam antibiotic 53 arthrography 53 intravesical 53 anti Neu5Gc antibodies 53 conventional DMARDs 53 factor TNF 53 nonischemic 53 serotonin receptor 53 anticlotting drugs 53 pharmacologic approaches 53 pulmonary artery pressure 53 racemic mixture 53 contra lateral 53 dorsolateral 53 disc degeneration 53 tibial plateau fractures 53 endogenous cannabinoid 53 cardiac dysfunction 53 molindone 53 prostacyclins 53 bypass grafting 53 detrusor 53 TGF beta pathway 53 logistic regression analyzes 53 GPIIb IIIa 53 Azathioprine 53 irinotecan chemotherapy 53 renal denervation 53 NMDA antagonist 53 mice genetically altered 53 lacosamide 53 selegiline 53 neuroregenerative 53 plasminogen activators 53 levosimendan 53 verapamil 53 PPAR alpha 53 Apidra ® 53 inactive placebo 53 capillary density 53 Akt phosphorylation 53 Fludarabine 53 canakinumab 53 antibiotic rifaximin 53 scintigraphic 53 glial tumors 53 carcinoids 53 eosinophil count 53 cortices 53 Coblation 53 relaxivity 53 Androgen receptor 53 Mitoxantrone 53 visuospatial skills 53 extrapyramidal symptoms EPS 53 adalimumab 53 PegIntron 53 Wnt signaling 53 hypothalamic pituitary 53 M1 muscarinic 53 desmopressin 53 HIPEC 53 TNFalpha 53 sinus node 53 stress cardiomyopathy 53 focally 53 TLR3 53 contractile function 53 Lamotrigine 53 H. pylori eradication 53 octreotide LAR 53 Valproic acid 53 frontal parietal 53 posterolateral fusion 53 adrenergic receptors 53 CorVue ™ 53 fusiform gyrus 53 angular gyrus 53 immunosuppressive regimen 53 mGluR 53 neuropsychological impairments 53 Th2 cytokines 53 ubiquinol 53 protein adsorption 53 Carvedilol 53 Cytoxan 53 detrusor overactivity 53 bolus injection 53 cochlear implantation 53 Thal Dex 53 PHY# [002] 53 conditional logistic regression 53 QTc interval 53 axonal regeneration 53 L lysine 53 cardiac magnetic resonance 53 pyrimidines 53 downregulating 53 pharmacotherapies 53 #F FDG PET 53 lactulose 52 carbidopa 52 trigeminal 52 diagnostically 52 mesalamine granules 52 anterior cortex 52 bone scintigraphy 52 artery stenosis 52 NKT cells 52 ATPase activity 52 TrkB 52 virologically 52 NRTI 52 bronchoalveolar lavage BAL